Hotel Leelaventure (HLVL) owns a chain of premium hotels across the Western and Southern regions of India. The company has emerged as one of the major players in the premium segment of the hospitality business and currently operates six properties, o... More
Oriental Hotels (Indian Hotels has around 19% stake directly and combined stake of the Tata Group stands at 33%) is a southern India focused player with a total inventory of 666 rooms. It operates 7 hotels: the Taj Coromandel (Chennai), Fisherman's... More
HLV | ORIENTAL HOTELS | HLV/ ORIENTAL HOTELS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 1.7 | -63.5 | - | View Chart |
P/BV | x | 1.1 | 0.8 | 137.7% | View Chart |
Dividend Yield | % | 0.0 | 2.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
HLV Mar-19 |
ORIENTAL HOTELS Mar-19 |
HLV/ ORIENTAL HOTELS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 22 | 59 | 36.3% | |
Low | Rs | 9 | 34 | 25.5% | |
Sales per share (Unadj.) | Rs | 2.4 | 19.4 | 12.6% | |
Earnings per share (Unadj.) | Rs | -0.6 | 4.9 | -12.3% | |
Cash flow per share (Unadj.) | Rs | -0.4 | 6.5 | -6.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0.50 | 0.0% | |
Dividend yield (eoy) | % | 0 | 1.1 | 0.0% | |
Book value per share (Unadj.) | Rs | 4.2 | 29.9 | 14.1% | |
Shares outstanding (eoy) | m | 630.55 | 178.60 | 353.1% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 6.1 | 2.4 | 256.7% | |
Avg P/E ratio | x | -25.1 | 9.5 | -263.2% | |
P/CF ratio (eoy) | x | -33.6 | 7.2 | -467.5% | |
Price / Book Value ratio | x | 3.6 | 1.6 | 229.8% | |
Dividend payout | % | 0 | 10.3 | 0.0% | |
Avg Mkt Cap | Rs m | 9,490 | 8,305 | 114.3% | |
No. of employees | `000 | 2.3 | 0.8 | 296.5% | |
Total wages/salary | Rs m | 604 | 976 | 61.9% | |
Avg. sales/employee | Rs Th | 681.4 | 4,539.1 | 15.0% | |
Avg. wages/employee | Rs Th | 266.8 | 1,277.4 | 20.9% | |
Avg. net profit/employee | Rs Th | -166.8 | 1,139.3 | -14.6% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,543 | 3,468 | 44.5% | |
Other income | Rs m | 42 | 80 | 52.4% | |
Total revenues | Rs m | 1,585 | 3,548 | 44.7% | |
Gross profit | Rs m | -23 | 515 | -4.5% | |
Depreciation | Rs m | 96 | 284 | 33.8% | |
Interest | Rs m | 4 | 272 | 1.5% | |
Profit before tax | Rs m | -81 | 39 | -210.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | -297 | 962 | -30.8% | |
Tax | Rs m | 0 | 130 | 0.0% | |
Profit after tax | Rs m | -378 | 870 | -43.4% | |
Gross profit margin | % | -1.5 | 14.8 | -10.2% | |
Effective tax rate | % | 0 | 336.3 | 0.0% | |
Net profit margin | % | -24.5 | 25.1 | -97.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,163 | 1,379 | 84.3% | |
Current liabilities | Rs m | 30,399 | 3,089 | 984.0% | |
Net working cap to sales | % | -1,894.2 | -49.3 | 3,840.4% | |
Current ratio | x | 0 | 0.4 | 8.6% | |
Inventory Days | Days | 19 | 8 | 245.7% | |
Debtors Days | Days | 155 | 14 | 1,070.7% | |
Net fixed assets | Rs m | 3,446 | 3,961 | 87.0% | |
Share capital | Rs m | 1,261 | 179 | 706.1% | |
"Free" reserves | Rs m | 1,394 | 5,160 | 27.0% | |
Net worth | Rs m | 2,655 | 5,338 | 49.7% | |
Long term debt | Rs m | 7,105 | 0 | - | |
Total assets | Rs m | 41,888 | 8,519 | 491.7% | |
Interest coverage | x | -19.3 | 1.1 | -1,692.2% | |
Debt to equity ratio | x | 2.7 | 0 | - | |
Sales to assets ratio | x | 0 | 0.4 | 9.1% | |
Return on assets | % | -0.9 | 13.4 | -6.7% | |
Return on equity | % | -14.2 | 16.3 | -87.3% | |
Return on capital | % | -3.8 | 23.8 | -16.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 3,165 | 964 | 328.4% | |
Fx outflow | Rs m | 364 | 133 | 274.3% | |
Net fx | Rs m | 2,801 | 831 | 337.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,094 | 380 | 550.7% | |
From Investments | Rs m | 1,289 | 822 | 156.8% | |
From Financial Activity | Rs m | -3,270 | -977 | 334.9% | |
Net Cashflow | Rs m | 112 | 225 | 49.8% |
Indian Promoters | % | 63.9 | 51.0 | 125.3% | |
Foreign collaborators | % | 0.0 | 6.3 | - | |
Indian inst/Mut Fund | % | 5.3 | 10.7 | 49.5% | |
FIIs | % | 0.5 | 0.0 | - | |
ADR/GDR | % | 0.0 | 11.5 | - | |
Free float | % | 30.3 | 20.6 | 147.1% | |
Shareholders | 111,944 | 13,801 | 811.1% | ||
Pledged promoter(s) holding | % | 88.6 | 1.8 | 4,950.8% |
Compare HLV With: THE BYKE HOSPITALITY ASIAN HOTELS (NORTH) U.P. HOTELS MAHINDRA HOLIDAYS TAJ GVK
Compare HLV With: INTER. HOTELS (UK) MARRIOT (US) SUN INTL. (S. Africa) TSOGO SUN (S. Africa)
Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.
For the quarter ended December 2019, ORIENTAL HOTELS has posted a net profit of Rs 51 m (down 65.8% YoY). Sales on the other hand came in at Rs 842 m (down 6.3% YoY). Read on for a complete analysis of ORIENTAL HOTELS's quarterly results.
For the quarter ended June 2019, ORIENTAL HOTELS has posted a net profit of Rs 57 m (down 60.1% YoY). Sales on the other hand came in at Rs 661 m (down 18.6% YoY). Read on for a complete analysis of ORIENTAL HOTELS's quarterly results.
For the quarter ended March 2019, HOTEL LEELAVENT. has posted a net profit of Rs 298 m (down 88.7% YoY). Sales on the other hand came in at Rs 431 m (down 79.1% YoY). Read on for a complete analysis of HOTEL LEELAVENT.'s quarterly results.
For the quarter ended March 2019, ORIENTAL HOTELS has posted a net profit of Rs 146 m (up 153.6% YoY). Sales on the other hand came in at Rs 926 m (down 5.7% YoY). Read on for a complete analysis of ORIENTAL HOTELS's quarterly results.
For the quarter ended December 2018, HOTEL LEELAVENT. has posted a net profit of Rs 441 m (up 8.6% YoY). Sales on the other hand came in at Rs 2 bn (up 2.7% YoY). Read on for a complete analysis of HOTEL LEELAVENT.'s quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More